Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded
- Contract number
- SPE2DB25FNWNJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,156
Award facts
- Contract value 100% obligated
- $15,156.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of XGEVA 120 mg/1.7 mL vials with a contract value of $15,156.18 and ultimate completion date of September 16, 2025. This non-competitive delivery order utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. XGEVA is a prescription medication used primarily for the treatment of bone metastases and osteoporosis, representing part of the Defense Logistics Agency's Medical Supply Chain procurement activities to support military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, leverages this prime contract vehicle to serve customers including the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FNWNJ?
SPE2DB25FNWNJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FNWNJ worth?
The government has obligated $15,156 on SPE2DB25FNWNJ.
Is contract SPE2DB25FNWNJ an order under another contract?
Yes. SPE2DB25FNWNJ is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNWNJ competed?
The extent of competition for SPE2DB25FNWNJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award